HRMY
Harmony Biosciences Holdings, Inc.
$34.46
-2.10%
$2.0B
No data for this timeframe.
Vol
Market Cap$2.0B
Cap SizeSmall Cap
Analyst ConsensusBuy (65%)
Inst. Holders50 funds
Inst. Value$918.9M
Inst. Activity26 buys / 12 sells
Reddit Sentiment50° Neutral
SEC Reports7
Recent Activity
Jun 9, 2026
SEC
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell up to 27,960 shares (~$943K at recent prices), a
144 — Impact 3/10
Jun 5, 2026
SEC
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell 2,101 shares of Harmony Biosciences (HRMY) with
144 — Impact 3/10
May 19, 2026
SEC
Geno Germano filed an initial Form 3 statement of beneficial ownership with the SEC, listing himself as a reporting insi
3 — Impact 5/10
May 14, 2026
Insider
Szyper Linda M was granted 21,872 shares
Director
May 14, 2026
Insider
Sabater Juan A. was granted 21,872 shares
Director
May 14, 2026
Insider
Graf R. Mark was granted 21,872 shares
Director
Inst.
MORGAN STANLEY — ADD
1,031,018 shares ($28.9M)
Inst.
Invesco Ltd. — ADD
628,247 shares ($17.6M)
Price Targets
$44.36
+28.7% upside
Strong Buy
Current $34.46
Low $28.00
Median $43.00
High $85.00
11 analysts
$28.00
$85.00
Analyst Ratings
3Strong Buy
8Buy
5Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 8, 2026 | Truist Securities | MAINTAIN | Hold → Hold |
| Feb 25, 2026 | UBS | MAINTAIN | Neutral → Neutral |
| Feb 25, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Feb 25, 2026 | B of A Securities | MAINTAIN | Underperform → Underperform |
| Feb 25, 2026 | Needham | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.10 ▼ -3.9% | $0.86 — $1.26 | 20% YoY | 3 |
| Next Q | $1.22 ▼ -5.3% | $0.93 — $1.46 | 13% YoY | 3 |
| Current FY | $4.39 ▼ -8.4% | $3.27 — $5.35 | 22% YoY | 4 |
| Next FY | $5.58 ▼ -3.6% | $4.16 — $7.30 | 27% YoY | 3 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $198.0M | — |
| FMR LLC | $88.4M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $76.0M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $58.9M | — |
| DIMENSIONAL FUND ADVISORS LP | $58.2M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 14, 2026 | Szyper Linda | A | $0.00 |
| May 14, 2026 | Sabater Juan | A | $0.00 |
| May 14, 2026 | Graf R. | A | $0.00 |
| May 14, 2026 | Sender Gary | A | $0.00 |
| May 14, 2026 | Philip Ron | A | $0.00 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
50 institutional holders with $918.9M total value (32,762,893 shares) as of 2026-Q1. Top holders: BlackRock,, FMR, VANGUARD. Net buying activity: 26 institutions added/increased vs 12 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7,070,035 | $198.0M | 21.6% | — |
| 2 | FMR LLC | 3,157,639 | $88.4M | 9.6% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2,714,353 | $76.0M | 8.3% | — |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2,102,315 | $58.9M | 6.4% | — |
| 5 | DIMENSIONAL FUND ADVISORS LP | 2,076,510 | $58.2M | 6.3% | — |
| 6 | STATE STREET CORP | 1,784,362 | $50.0M | 5.4% | — |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,382,113 | $38.7M | 4.2% | — |
| 8 | GOLDMAN SACHS GROUP INC | 1,239,207 | $34.7M | 3.8% | — |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 1,077,371 | $30.2M | 3.3% | — |
| 10 | MORGAN STANLEY | 1,031,018 | $28.9M | 3.1% | ADD +26.1% |
| 11 | TWO SIGMA INVESTMENTS, LP | 733,443 | $20.5M | 2.2% | — |
| 12 | Invesco Ltd. | 628,247 | $17.6M | 1.9% | ADD +39.4% |
| 13 | Trexquant Investment LP | 594,850 | $16.7M | 1.8% | ADD +98.7% |
| 14 | CITADEL ADVISORS LLC | 585,623 | $16.4M | 1.8% | — |
| 15 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 567,115 | $15.9M | 1.7% | ADD +72.8% |
| 16 | NOMURA HOLDINGS INC | 520,947 | $14.6M | 1.6% | — |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 411,597 | $11.5M | 1.3% | — |
| 18 | ROYCE & ASSOCIATES LP | 356,671 | $10.0M | 1.1% | ADD +28.2% |
| 19 | VICTORY CAPITAL MANAGEMENT INC | 351,630 | $9.8M | 1.1% | ADD +29.0% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 286,217 | $8.0M | 0.9% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 817,507 | 1,031,018 | +26.1% | $28.9M | 2026-Q1 |
| Invesco Ltd. | ADD | 450,805 | 628,247 | +39.4% | $17.6M | 2026-Q1 |
| Trexquant Investment LP | ADD | 299,404 | 594,850 | +98.7% | $16.7M | 2026-Q1 |
| ROYCE & ASSOCIATES LP | ADD | 278,188 | 356,671 | +28.2% | $10.0M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | ADD | 272,572 | 351,630 | +29.0% | $9.8M | 2026-Q1 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | TRIM | 541,281 | 270,013 | -50.1% | $7.6M | 2026-Q1 |
| SEI INVESTMENTS CO | DOUBLED | 73,634 | 194,188 | +163.7% | $5.4M | 2026-Q1 |
| FRANKLIN RESOURCES INC | DOUBLED | 46,346 | 188,140 | +305.9% | $5.3M | 2026-Q1 |
| DEUTSCHE BANK AG\ | TRIM | 344,171 | 184,945 | -46.3% | $5.2M | 2026-Q1 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | TRIM | 248,107 | 180,241 | -27.4% | $5.0M | 2026-Q1 |
| Allspring Global Investments Holdings, LLC | DOUBLED | 20,725 | 176,219 | +750.3% | $4.9M | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | DOUBLED | 66,551 | 166,198 | +149.7% | $4.7M | 2026-Q1 |
| MARSHALL WACE, LLP | DOUBLED | 29,434 | 149,715 | +408.6% | $4.2M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 275,058 | 140,717 | -48.8% | $3.9M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | TRIM | 155,354 | 104,549 | -32.7% | $2.9M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 249,124 | 101,110 | -59.4% | $2.8M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | TRIM | 221,454 | 98,676 | -55.4% | $2.8M | 2026-Q1 |
| EXCHANGE TRADED CONCEPTS, LLC | ADD | 57,473 | 87,012 | +51.4% | $2.4M | 2026-Q1 |
| MACKENZIE FINANCIAL CORP | ADD | 40,696 | 72,912 | +79.2% | $2.0M | 2026-Q1 |
| Gotham Asset Management, LLC | DOUBLED | 31,773 | 64,184 | +102.0% | $1.8M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 40,552 | 51,786 | +27.7% | $1.5M | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | ADD | 28,802 | 38,534 | +33.8% | $1.1M | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 347 | 37,657 | +10752.2% | $1.1M | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | TRIM | 51,200 | 31,100 | -39.3% | $871.1K | 2026-Q1 |
| OMERS ADMINISTRATION Corp | DOUBLED | 12,690 | 30,990 | +144.2% | $868.0K | 2026-Q1 |
11 unique insiders with 13 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2026 | Szyper Linda M | Director | AWARD | 21,872 | — | — |
| May 14, 2026 | Sabater Juan A. | Director | AWARD | 21,872 | — | — |
| May 14, 2026 | Graf R. Mark | Director | AWARD | 21,872 | — | — |
| May 14, 2026 | Sender Gary | Director | AWARD | 21,872 | — | — |
| May 14, 2026 | Philip Ron M | Director | AWARD | 21,872 | — | — |
| May 14, 2026 | Germano Geno J | Director | AWARD | 21,231 | — | — |
| May 1, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | TAX W/H | 8,882 | $31.83 | $282.7K |
| May 1, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | EXERCISE | 18,750 | — | — |
| Apr 14, 2026 | Reicin Glenn | CHIEF FINANCIAL OFFICER | AWARD | 164,309 | — | — |
| Apr 7, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | TAX W/H | 3,173 | $27.62 | $87.6K |
| Apr 7, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | EXERCISE | 7,500 | — | — |
| Apr 2, 2026 | Ignelzi Troy A. | Director | AWARD | 17,710 | — | — |
| Apr 2, 2026 | Anastasiou Peter | CHIEF OPERATING OFFICER | AWARD | 212,241 | — | — |
7 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 5 neutral. Avg impact: 4.0/10.
NEUTRAL
144
3/10
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell up to 27,960 shares (~$943K
Jun 9, 2026
NEUTRAL
144
3/10
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell 2,101 shares of Harmony Bios
Jun 5, 2026
NEUTRAL
3
5/10
Geno Germano filed an initial Form 3 statement of beneficial ownership with the SEC, listing himself
May 19, 2026
MIXED
8-K
5/10
Harmony Biosciences reported Q1 2026 revenue of $215.4M (+17% YoY), slightly below consensus of $220
May 7, 2026
MIXED
8-K
6/10
Harmony Biosciences announced the departure of CFO Sandip Kapadia and the immediate appointment of G
Apr 14, 2026
NEUTRAL
DEFA14A
3/10
Harmony Biosciences filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting, where
Apr 3, 2026
NEUTRAL
8-K
3/10
Harmony Biosciences appointed Peter Anastasiou as Chief Operating Officer and board member Troy Igne
Apr 2, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (65% buy). Based on 17 analysts: 3 strong buy, 8 buy, 5 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$44.36 mean target
+28.7% upside
Strong Buy (3.00)
$28.00 Low
$85.00 High
| Metric | Value |
|---|---|
| Current Price | $34.46 |
| Target Low | $28.00 |
| Target Mean | $44.36 |
| Target Median | $43.00 |
| Target High | $85.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.10 | $0.86 | $1.26 | 19.5% | -3.9% | 1↑ 1↓ | $0.2B | 22.0% | 3 |
| Next Q 2026-09-30 |
$1.22 | $0.93 | $1.46 | 13.4% | -5.3% | 1↑ 1↓ | $0.3B | 13.0% | 3 |
| Current FY 2026-12-31 |
$4.39 | $3.27 | $5.35 | 22.0% | -8.4% | 0↑ 2↓ | $1.0B | 16.8% | 4 |
| Next FY 2027-12-31 |
$5.58 | $4.16 | $7.30 | 27.1% | -3.6% | 2↑ 1↓ | $1.1B | 13.3% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.100 | |
| 7d ago | $1.166 | -0.066 |
| 30d ago | $1.144 | -0.045 |
| 60d ago | $1.144 | -0.045 |
| 90d ago | $1.231 | -0.131 |
5 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 8, 2026 | Truist Securities | MAINTAIN | Hold | Hold |
| Feb 25, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Feb 25, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 25, 2026 | B of A Securities | MAINTAIN | Underperform | Underperform |
| Feb 25, 2026 | Needham | MAINTAIN | Buy | Buy |
| Feb 11, 2026 | UBS | DOWNGRADE | Buy | Neutral |
| Jan 8, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 8 | 5 | 1 | 0 | 65% | |
| May 1, 2026 | 3 | 8 | 5 | 1 | 0 | 65% | |
| Apr 1, 2026 | 3 | 8 | 5 | 1 | 0 | 65% | |
| Mar 1, 2026 | 3 | 8 | 5 | 1 | 0 | 65% | |
| Feb 1, 2026 | 3 | 11 | 2 | 1 | 0 | 82% | |
| Jan 1, 2026 | 3 | 11 | 2 | 1 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
2 mentions
0 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 11, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 11, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
HRMY: opportunity or value trap?
▲ 1
💬 0
⚡ 0.5
Mar 31, 2027
fda_pdufa
PDUFA: HRMY — Pitolisant GR in narcolepsy (Adults) — 2027-03-31
FDA target action date 2027-03-31 for HRMY (Harmony Biosciences Holdings, Inc.). Drug: Pitolisant GR. Indication: narcolepsy (Adults). Anticipated PDU
Jun 10, 2026
short_volume
Short Volume: HRMY — 62.6% short (0.5M / 0.8M)
Short: 474,798 | Exempt: 0 | TRF Vol: 758,945 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
HRMY Q1 2026 Earnings Scheduled — 2026-05-07
May 7, 2026
short_volume
Short Volume: HRMY — 73.2% short (0.7M / 1.0M)
Short: 706,522 | Exempt: 14,065 | TRF Vol: 964,606 | Short Ratio: 73.2% | Off-exchange volume (dark pool + OTC)
Apr 23, 2026
short_volume
Short Volume: HRMY — 81.7% short (0.5M / 0.7M)
Short: 533,143 | Exempt: 0 | TRF Vol: 652,934 | Short Ratio: 81.7% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
short_volume
Short Volume: HRMY — 63.5% short (0.4M / 0.6M)
Short: 406,372 | Exempt: 0 | TRF Vol: 639,829 | Short Ratio: 63.5% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
short_volume
Short Volume: HRMY — 69.0% short (1.2M / 1.7M)
Short: 1,174,426 | Exempt: 1,633 | TRF Vol: 1,701,736 | Short Ratio: 69.0% | Off-exchange volume (dark pool + OTC)
Feb 24, 2026
earnings_calendar
HRMY Q4 2025 Earnings Before Market Open — 2026-02-24